SEC Form 4 · accession 0000805928-26-000098
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amy McBride Wendell
Director
Period of report
Aug 11, 2026
Accepted (ET)
Aug 12, 2026 · 4:12 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000805928
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 11, 2026 | M | 13,353 | $14.85 | A | 121,329 | D | |
| Common StockF2 | Aug 11, 2026 | S | 13,353 | $48.423 | D | 107,976 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to purchase)F3 | $14.85 | Aug 11, 2026 | M | 13,353 | D | — | Jun 1, 2027 | Common Stock | 13,353 | 0 | D |
Explanation of responses
- F1The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2026.
- F2The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $47.82 to $49.02 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F3All shares of Axogen, Inc. common stock underlying the board of director's stock option were fully vested on May 14, 2018.